4-Pyridinecarboxylic acid, [(5.alpha.,17.beta.)-17-hydroxyandrostan-3-ylidene]hydrazide
TL;DR: 4-Pyridinecarboxylic acid, [(5.alpha.,17.beta.)-17-hydroxyandrostan-3-ylidene]hydrazide (CAS 3701-50-6) is a chemical compound with molecular formula C25H35N3O2 and molecular weight 409.27 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
N-[(Z)-[(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ylidene]amino]pyridine-4-carboxamide
Also Known As: 4-Pyridinecarboxylic acid, [(5.alpha.,17.beta.)-17-hydroxyandrostan-3-ylidene]hydrazide, N-[(Z)-[(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ylidene]amino]pyridine-4-carboxamide
| Molecular Formula | C25H35N3O2 |
|---|---|
| Molecular Weight | 409.27 g/mol |
| LogP | 4.571 |
| Topological Polar Surface Area | 74.58 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 4 |
| Rotatable Bonds | 2 |
| Exact Mass | 409.27292 |
| Heavy Atoms | 30 |
| Complexity | 840.0553 |
Chemical Identifiers
| CAS Number | 3701-50-6 |
|---|---|
| SMILES | C[C@]12CC/C(=N/NC(=O)C3=CC=NC=C3)/C[C@@H]1CC[C@@H]4[C@@H]2CC[C@]5([C@H]4CC[C@@H]5O)C |
Product Overview
4-Pyridinecarboxylic acid, [(5.alpha.,17.beta.)-17-hydroxyandrostan-3-ylidene]hydrazide (CAS 3701-50-6), with molecular formula C25H35N3O2 and molecular weight 409.27 g/mol. IUPAC: N-[(Z)-[(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ylidene]amino]pyridine-4-carboxamide.
Chemical Property Profile of 4-Pyridinecarboxylic acid, [(5.alpha.,17.beta.)-17-hydroxyandrostan-3-ylidene]hydrazide
Property Insights of 4-Pyridinecarboxylic acid, [(5.alpha.,17.beta.)-17-hydroxyandrostan-3-ylidene]hydrazide
The XLogP value of 4.571 indicates that 4-Pyridinecarboxylic acid, [(5.alpha.,17.beta.)-17-hydroxyandrostan-3-ylidene]hydrazide is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 74.58 Ų falls within the moderate polarity range, balancing permeability and solubility for 4-Pyridinecarboxylic acid, [(5.alpha.,17.beta.)-17-hydroxyandrostan-3-ylidene]hydrazide. Following Lipinski's Rule of Five, 4-Pyridinecarboxylic acid, [(5.alpha.,17.beta.)-17-hydroxyandrostan-3-ylidene]hydrazide has 2 hydrogen bond donor(s) and 4 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 4-Pyridinecarboxylic acid, [(5.alpha.,17.beta.)-17-hydroxyandrostan-3-ylidene]hydrazide?
The CAS number of 4-Pyridinecarboxylic acid, [(5.alpha.,17.beta.)-17-hydroxyandrostan-3-ylidene]hydrazide is 3701-50-6.
What is the molecular formula of 4-Pyridinecarboxylic acid, [(5.alpha.,17.beta.)-17-hydroxyandrostan-3-ylidene]hydrazide?
The molecular formula of 4-Pyridinecarboxylic acid, [(5.alpha.,17.beta.)-17-hydroxyandrostan-3-ylidene]hydrazide is C25H35N3O2.
What is the molecular weight of 4-Pyridinecarboxylic acid, [(5.alpha.,17.beta.)-17-hydroxyandrostan-3-ylidene]hydrazide?
The molecular weight of 4-Pyridinecarboxylic acid, [(5.alpha.,17.beta.)-17-hydroxyandrostan-3-ylidene]hydrazide is 409.27 g/mol.
Where can I buy 4-Pyridinecarboxylic acid, [(5.alpha.,17.beta.)-17-hydroxyandrostan-3-ylidene]hydrazide?
You can request a quote for 4-Pyridinecarboxylic acid, [(5.alpha.,17.beta.)-17-hydroxyandrostan-3-ylidene]hydrazide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 4-Pyridinecarboxylic acid, [(5.alpha.,17.beta.)-17-hydroxyandrostan-3-ylidene]hydrazide?
Yes, KEHONG BIO provides custom synthesis services for 4-Pyridinecarboxylic acid, [(5.alpha.,17.beta.)-17-hydroxyandrostan-3-ylidene]hydrazide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.